As evidentiary requirements in the in vitro diagnostic (IVD) market increase, manufacturers are under greater pressure to demonstrate the value of their products as soon as they enter the market in order to ensure routine coverage by healthcare insurers. "Value" in this case has a broad ...
Please Login to read the full article.
